Skip to main content
Premium Trial:

Request an Annual Quote

Quebec Research Center Receives $12.8M for Gene Expression Study of Steriod Use

SAN FRANCISCO, Dec. 20 - The Centre Hospitalier Universitaire de Quebec received a commitment for $10 million Canadian ($6.4 million) each from Genome Quebec and Genome Canada to fund a project to study the changes in gene expression that occur from steroid treatment.

 

The funding is part of $40 million Canadian ($25.3 million) earmarked for Quebec by Genome Canada, the Canadian genomics research organization. Genome Quebec is the provincial arm of Genome Canada.

 

"Dr. Labrie's [of CHUQ] research work will lead to a better basic understanding of steroids' impact on the human genome and open up new and significant progress opportunities in the fight against disease," Martin Godbout, CEO of Genome Canada, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more